Cannabis: Current Trends and Research Emily Leuer January 21, 2020 - - PowerPoint PPT Presentation

cannabis current trends and research
SMART_READER_LITE
LIVE PREVIEW

Cannabis: Current Trends and Research Emily Leuer January 21, 2020 - - PowerPoint PPT Presentation

Cannabis: Current Trends and Research Emily Leuer January 21, 2020 Agenda Vireo Health Overview Cannabis: Hemp vs Marijuana Minnesota Medical Marijuana How Cannabis Interacts with the Human Body Cannabinoids Terpenes


slide-1
SLIDE 1

Cannabis: Current Trends and Research

Emily Leuer January 21, 2020

slide-2
SLIDE 2

Agenda

  • Vireo Health Overview
  • Cannabis: Hemp vs Marijuana
  • Minnesota Medical Marijuana
  • How Cannabis Interacts with the Human Body
  • Cannabinoids
  • Terpenes
  • Formulating with Cannabis
slide-3
SLIDE 3

Vireo Health Overview

slide-4
SLIDE 4
slide-5
SLIDE 5

Vireo Health

  • On track to be in 11 states
  • Minnesota Medical Solutions
  • Pennsylvania Medical Solutions
  • Maryland: MaryMed
  • Ohio Medical Solutions
  • Vireo New York
  • Rhode Island, Arizona, Massachusetts, Nevada, New Mexico, & Puerto Rico
  • Headquartered in Minneapolis
  • For more information: https://vireohealth.com/
slide-6
SLIDE 6

Cannabis: Hemp vs Marijuana

slide-7
SLIDE 7

Hemp vs Marijuana

  • 2018 Farm Bill legalized farming of industrial hemp
  • Surge of CBD products since the change
  • Biologically, they are the same plant
  • Hemp: ≤ 0.3% THC (dry basis)
  • Marijuana: > 0.3% THC
  • Typically 5-20% THC
slide-8
SLIDE 8

FDA Stance on CBD

  • “It is currently illegal to market CBD by adding it to food or labeling it

as a dietary supplement”

  • “Some CBD products are being marketed with unproven medical

claims and could produced with unsafe manufacturing processes”

  • For more information:
  • https://www.fda.gov/news-events/public-health-focus/fda-regulation-

cannabis-and-cannabis-derived-products-including-cannabidiol-cbd

  • Or, Google FDA and CBD
slide-9
SLIDE 9

Medical Marijuana Products

  • Testing protocol varies by state, but in general, medical products are

tested for the following:

  • Potency
  • %THC, %CBD
  • Heavy Metals
  • Arsenic, lead, mercury, chromium, cadmium
  • Pesticides
  • Residual solvents
  • Ethanol, hexane, pentane
  • Microbials
  • Salmonella, coliform, yeast, mold, aerobic bacteria, gram negative bacteria
slide-10
SLIDE 10

Minnesota Medical Marijuana

slide-11
SLIDE 11
slide-12
SLIDE 12

Qualifying Conditions

slide-13
SLIDE 13

Changes to MN MMJ in August, 2020

  • New delivery methods
  • Water-soluble cannabis powder
  • Orally dissolvable lozenges and mints
  • New qualifying conditions
  • Chronic pain
  • Macular degeneration
  • More dispensaries
  • Vireo: Woodbury, Blaine, Burnsville, Duluth
  • Leafline: Willmar, Mankato, Golden Valley, Rogers
slide-14
SLIDE 14

How Cannabis Interacts with the Human Body

slide-15
SLIDE 15

Endocannabinoid System

  • The human endocannabinoid system was discovered in the 1990s
  • The endocannabinoid system exists to retain homeostasis
  • The endocannabinoid system is very old (500 MM years +) and exists

in all vertebrates

  • Receptors were originally thought to only exist in the brain but have

since been discovered throughout the body

  • Muscle, organs, blood vessels
  • Plays a role in many processes
  • Sleep, stress, pain, mood, immunity, appetite, memory

Source: UCLA Health Cannabis Research Initiative

slide-16
SLIDE 16

Cannabis and the Endocannabinoid System

  • Different cannabinoids bind with different endocannabinoid receptors
  • THC works similarly to a neurotransmitter naturally produced in the human

body call anandamide

  • Both THC and anandamide interact with CB1 receptors
  • Anandamide may also affect pain and provide a sense of euphoria
  • May be responsible for “runner’s high”
  • Endorphins cannot cross the blood-brain barrier whereas anandamide can
  • Also found in chocolate
  • There are potentially over one hundred cannabinoids in marijuana and
  • ver three hundred terpenes, each of which may interact individually

within the human body or synergistically (aka the entourage effect)

slide-17
SLIDE 17

Cannabinoids

Sources for this section: Leafly.com Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads, E.B. Russo& J. Marcu, 2017

slide-18
SLIDE 18

Acid Form vs Neutral Form

slide-19
SLIDE 19

THCA – Tetrahydrocannabinolic Acid

  • Does not produce euphoric effects
  • Preliminary research shows….
  • Anti-inflammatory properties
  • Neuroprotective
  • Anti-emetic properties
slide-20
SLIDE 20

THC: Tetrahydrocannabinol

  • Does produce euphoric effects
  • Interacts with CB1 and CB2 receptors
  • Short-term effects from THC
  • Relaxation, sedation, pain relief, memory impairment, hunger, anxiety
  • Currently used as treatment for:
  • Nausea, appetite loss, insomnia, pain management, etc
  • Studies show it may have 20x the anti-inflammatory power of aspirin

and 2x hydrocortisone

slide-21
SLIDE 21

CBDA – Cannabidiolic Acid

  • A study in 2008 showed CBDA may act as a COX-2 inhibitor
  • May be able to be used as a substitute for NSAIDs
  • May have better bioavailability than CBD
  • May have anti-convulsant properties
  • May have anti-depressant properties
slide-22
SLIDE 22

CBD: Cannabidiol

  • Low affinity for CB receptors but may possess CB1 and CB2 independent

mechanisms

  • Shown to have anticonvulsive, anti-inflammatory, antioxidant, and

antipsychotic effects.

  • Currently used to treat the following:
  • Epilepsy and seizure disorders
  • Crohn’s disease
  • Multiple sclerosis
  • PTSD
  • Anxiety
  • Pain/inflammation
  • Alzheimer’s
  • Huntington disease
slide-23
SLIDE 23

CBG - Cannabigerol

  • Current research involving mice shows:
  • May be effective in treating glaucoma
  • May decrease inflammation in inflammatory bowel disease
  • May protect neurons with Huntington’s disease
  • May help to fight cancer cell growth
  • May be a non-psychoactive appetite stimulant
  • A study from 1975 shows CBG supports GABA uptake inhibition

greater than either THC or CBD and provide muscle relaxation effects

  • A 2011 study showed CBG was effective against MRSA
slide-24
SLIDE 24

CBC - Cannabichromene

  • Appears to interact with CB2 receptors but not CB1
  • May be a powerful anti-cancer agent
  • May help with inflammation
  • May have a synergistic effect with THC on inflammation
  • May fight acne
  • May work with THC and CBD as an anti-depressant
slide-25
SLIDE 25

THCV - Tetrahydrocannabivarin

  • May be both agonistic and antagonistic on CB1 receptors
  • May suppress appetite
  • A 2007 study showed THCV lead to weight loss, lower levels of body

fat, and increased energy in mice

  • May help regulate blood sugar levels and help with diabetes
  • May reduce occurrence of panic attacks
  • May help with Alzheimer’s
  • May stimulate bone growth
slide-26
SLIDE 26

CBN - Cannabinol

  • Breakdown product of THC
  • Some studies show it has sedative properties when combined with

THC

  • May have anticonvulsant properties
  • May be anti-inflammatory
  • May have antibiotic properties
  • May be effective against MRSA
  • May show promise against psoriasis in topicals
slide-27
SLIDE 27

Terpenes

Source for this section: Cannabis Pharmacology: The Usual Suspects and a Few Promising Leads, E.B. Russo & J. Marcu, 2017

slide-28
SLIDE 28

ß-Myrcene

  • Current research shows
  • Anti-inflammatory
  • Sedative
  • May cause “couch-lock” effects in

some cannabis chemovars

  • A 2014 study suggests myrcene

works synergistically with THC and CBD offering neuroprotective antioxidant effects

  • Also found in
  • Mangoes
  • Hops
  • Bay leaves
  • Lemongrass
  • Eucalyptus
  • Cardamom
  • Flavor
  • Green mango
slide-29
SLIDE 29

ß-Caryophyllene

  • Current research shows
  • Anti-inflammatory
  • Cardioprotective
  • Neuroprotective
  • Hepatoprotective
  • Gastroprotective
  • Antimicrobial
  • Also found in
  • Black pepper
  • Cloves
  • Basil
  • Oregano
  • Cinnamon
  • Flavor
  • Spicy, warm
slide-30
SLIDE 30

α-Pinene

  • Current research shows
  • Anti-inflammatory
  • Bronchodilator
  • Antibiotic against MRSA
  • Acetylcholinesterase inhibitor
  • May counteract memory loss

association with THC

  • Also found in
  • Pine
  • Juniper
  • Rosemary
  • Flavor
  • Piney
slide-31
SLIDE 31

Linalool

  • Current research shows
  • Anti-anxiety
  • Sedative
  • Anti-depressant
  • Analgesic
  • Anticonvulsant
  • Also found in
  • Lavender
  • Rose
  • Basil
  • Neroli oil
  • Flavor
  • Soapy
slide-32
SLIDE 32

D-Limonene

  • Current research shows
  • A 2006 study with mice showed

limonene to have strong anti- anxiety effects

  • Stimulating effects
  • May inhibit cancer cell

proliferation

  • Antioxidant
  • Also found in
  • Citrus peels
  • Flavor
  • Citrus
slide-33
SLIDE 33

Formulating with Cannabis

Source for this section: Nanoparticle- and Microparticle-Based Delivery Systems, D.J. McClemets, 2015

slide-34
SLIDE 34

Cannabis Extracts are Lipids

  • Lipids dissolve easily in solvents (ethanol) and other lipids (MCT oil,

beeswax, etc)

  • Lipids do not mix well in water
slide-35
SLIDE 35

Creating an Emulsion

  • Mechanical means
  • Homogenizer
  • Ultrasonicator
  • Chemical means
  • Surfactant/emulsifier
  • Liposomes
slide-36
SLIDE 36

Creating an Emulsion - Homogenization

  • Feed enters the homogenizer via high pressure
  • The feed is forced through small spaces
  • This results in smaller lipid molecules
  • Multiple passes may be required
slide-37
SLIDE 37

Creating an Emulsion - Ultrasonication

Photo source: ScienceDirect.com

slide-38
SLIDE 38

Creating an Emulsion - Surfactants

  • Surfactants help stabilize an emulsion by lowering the surface tension

between two liquids

  • Many different types
  • Nonionic: tween, span, quillaja extract
  • Anionic: SLS, DATEM, CITREM
  • Cationic: lauric arginate
  • Zwitterionic: lecithin

Photo source: integratedhealthblog.com

slide-39
SLIDE 39

Thank you!